REFRACTORY TUMOR

Clinical trials for REFRACTORY TUMOR explained in plain language.

Never miss a new study

Get alerted when new REFRACTORY TUMOR trials appear

Sign up with your email to follow new studies for REFRACTORY TUMOR, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Completed 1

Experimental cancer drug tested in patients out of options

Disease control Completed

This early-stage study tested a new drug called DCR-STAT3 in adults with advanced solid tumors that had stopped responding to standard treatments. The main goal was to check the drug's safety and how the body processes it in 26 participants. Researchers also looked for early sign…

Matched conditions: REFRACTORY TUMOR

Phase: PHASE1 • Sponsor: Dicerna Pharmaceuticals, Inc., a Novo Nordisk company • Aim: Disease control

Last updated Apr 01, 2026 14:43 UTC

REFRACTORY TUMOR

Get alerted when new REFRACTORY TUMOR trials appear

Experimental cancer drug tested in patients out of options